Clinical trial

A Clinical Research Study Designed To Determine If Treatment of Hepatitis C With…

NCT00246363 · Henry Sacks, Other · Completed

Key facts

NCT number NCT00246363
Title A Clinical Research Study Designed To Determine If Treatment of Hepatitis C With Milk Thistle is More Effective Than No Treatment In Patients Infected With Both HIV And Hepatitis C
Official title A Pilot Randomized Placebo-Controlled Trial Designed to Determine the Tolerability and Efficacy of Silymarin (Milk Thistle) vs. Placebo for the Treatment of Chronic Hepatitis C in HIV Infected Patients
Lead sponsor Henry Sacks, Other
Collaborators National Institute of Nursing Research (NINR) NIH
Status Completed
Phase Phase 1/Phase 2
Study type Interventional
Conditions HIV Infections, Hepatitis C
Intervention type Drug
Interventions Silymarin, Placebo
Enrollment 40
Start date Jan 1, 2005
Primary completion Dec 1, 2007
Completion Dec 1, 2007
First posted Oct 31, 2005
Last update posted Sep 15, 2011
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies